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Being dendritic antigen-presenting cells in skin and mucous 
membrane, Langerhans. cells (LC) o~cur in ~eas at risk for 
inoculation by human lmmunodeficlency VlruS (HIV), and 
the question .whether LC act ~s a ta~get, reservoir, or vector 
for transmisslOn of HIV has glven me to much controversy. 
To address this question, we first analyzed the epidermal 
compartment of skin from patients seropositive for HIV 
DNA. Second, we tested the susceptibility of each cell type 
normally found in this compartment to in vitro infection by 
HIV -1 . A non-denatured 0 NA was obtained from epidermal 
sheets after a thermochemical treatment of biopsies (0.5 M 
ethylenediaminetetraacetic acid (EDT A), pH 7.5 at 60° C for 
90 seconds). Optimization of amplification of viral genome 
was performed with three primer pairs derived from gag, etlV, 
and pol sequences. Polymerase chain reaction (PCR) products 
were analyzed by Southern blot. Viral genome was found in 
L angerhans cells (Le) are bone marrow-derived den-dritic antigen-presenting cells localized in areas at risk for inoculation by human immunodeficiency virus (HIV). These cells are found in skin and mucous mem-branes, including oral, vaginal, and cervical epithelium. 
At present. it is no~ clear whether ~C pl~y t~e role <;>f a principal 
target, viral reservOIr, or. vector ~or dlssemmatlon of ViruS to lymp~ 
nodes within these phYSical barriers themselves [1- 3]. A large van-
ety of methodologies such as. electron microscopy, im~unocy.to­
chemistry, in Situ hybndlzatlon, and polymerase cham reaction 
(PCR) amplification of virus-specific DN.A led to .apparen.t differ-
ences in the number of LC thought to be mfected III HIV -mfected 
patients. Seve~al reflorts have suggested the p~ssibil~ty of in vivo and 
in vitro infection ofLC [4- 9], whereas other mvestlgators found no 
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EC: epidermal cells 
EDTA: ethylenediaminetetraacetic acid 
HIV: human immunodeficiency virus 
LC: Langerhans cells 
PCR: polymerase chain reaction 
five of 11 HIV-seropositive patients. To control the permis-
sivity of epidermal cell population for HIV, cells isolated 
from the epidermal sheet of normal skin by trypsinization 
were co-cultured with HIV-1-carrying promonocytic cells 
(U937) and observed by electron microscopy. After 3 - 6 h of 
co-culture, numerous virions were either tightly bound or 
apparently engaged in the process of internalization through 
receptor-mediated endocytosis. At day 4 of co-culture, some 
infected LC appeared to release mature viral particles 
through bud formation. The in vitro HIV-1 entry and repli-
cation in LC may confirm the presence of the HIV -1 genome 
by PCR in epidermis of seropositive patients. The conse-
quences of the permissivity of LC for HIV on the antigen-
presenting function remain to be determined.] Invest Derma-
tol 99:99S -1 02S, 1992 
evidence for virus infection [10,11]. If LC infection does occur this 
can rarely be demonstrated because of a low viral load in a very few 
infected cells and the low sensitivity of conventional immunohisto-
chemistry techniques. Among those techniques offering high sensi-
tivity, PCR seemed to be able to detect rare HIV -DNA sequences in 
in vivo material. Furthermore, in clinical specimens, because the 
dermal compartment may contain a great variety of cell types from 
peripheral blood, which are potentially HIV-infected, it seemed 
important to avoid any contamination of epidermis by these cells 
during the separation of the two cutaneous compartments. To this 
aim, we selected a technique for a clean detachment of the epider-
mal compartment, which was then analyzed for the presence of 
HIV-DNA. To control the permissivity of cells localized in the 
epidermis for HIV, we co-cultured isolated epidermal cells (Ee) 
with chronically HIV -1- infected U937 cells. 
DETECTION OF HIV-l-SPECIFIC DNA IN THE 
EPIDERMAL COMPARTMENT OF SKIN FROM HIV-
INFECTED PATIENTS: OPTIMIZATION OF THE 
DERMO-EPIDERMAL CLEAVAGE AND peR 
AMPLIFICATION 
We selected, among five dermo-epidermal separation techniques, 
the one that was suitable for screening either fresh or frozen cutane-
ous biopsies and allowed an easy detachment of the epidermis from 
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Figure 1. Representative results of PCR analysis of HIV -1 - specific DNA 
sequences in gag gene from epidermis of HIV -seropositive patients, HIV-
seronegative subjects, and controls. Lanes 1, 5- 10: seropositive patients. 
La/Jes 2, 3, 12: negative controls (2 seronegative subjects and non-infected 
H9 cells). Lanes 4, 11: positive controls (peripheral blood leukocytes of one 
seropositive patient, HIV-l-infected H9 cells). 
the dermis without contamination. The three enzymatic treatments 
tested were 1) 0.3% trypsin at 4°C for 16 h, 2) 1500 U/ml of 
collagenase at 4°C for 16 h, and 37°C for 3 h, and 3) 1.2 U/ml of 
dispase at 4°C for 16 h, and 37°C for 1 h. Two chemical treatments 
tested were 0.5 M ethylenediaminetetraacetic acid (EDT A), pH 7.5 
at 60 °C for 90 seconds, and 1 M NaCI at 4°C for 72 h. Either cell 
suspensions or'epidermal sheets were rinsed in 0.9% NaCI before 
lysis by proteinase K (500 J.lg/ml). DNA was extracted by phenoll 
ch loroform to avoid the presence of inhibitors. Among these five 
methods, the thermochemical treatment by EDT A provided the 
easiest and quickest separation of epidermis from dermis, either 
from fresh or frozen biopsies, and allowed at least 10 J.lg of non-
denatured DNA to be obtained from 6-mm punch biopsies. This 
procedure was applied to clinical specimens. After informed con-
sent, 11 seropositive patients and eight seronegative subjects under-
went skin biopsies by routine punch (6 mm). 
We improved the amplification of HIV-1-specific DNA se-
quences from epidermal DNA by testing different MgClz concen-
trations (from 1 to 7.5 mM MgClz) and different annealing tempera-
ture (55 °C, 58°C, and 60°C). These two parameters are known to 
modify greatly the sensitivity and specificity of the amplification. 
The use of 2.5 roM MgClz and 58°C annealing temperature al-
lowed detection of 1 to 10 copies of HBlO clone (HTLVIIl-B 
isolate) whatever the pair of primers considered (P1-P2 or SK38-39, 
P3-P4) (Table I). The best efficacy and the specificity of amplifica-
Table I. Location of Oligonucleotide Primer Pairs and Probes 
in the HIV -1 Genome 
Location on 
Viral Genome 
(BH-I0 Clone, 
Primers Probes Gene Regions HTL VIII -B Isolate) 
P1 = SK38 gag 1088-1115 
P2 = SK39 gag 1175-1202 
Prob 1 = SK19 gag 1133 - 1173 
P3 env 7378 - 7396 
P4 ellv 7509 - 7527 
Prob2 ellv 7451-7477 
P5 pol 3730-3755 
P6 pol 3858-3883 
Prob3 pol 3811- 3792 
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tion were obtained for an annealing step temperature of 55 ° C in-
stead of 58 °C from epidermal DNA. Figure 1 shows a typical analy-
sis of PCR-amplified products of epidermal compartment DNA. 
PCR amplification was considered positive when a Southern blot 
signal was found for at least two of the three primer pairs. HIV -1-
specific DNA was detected in 5 of 11 epidermis of skin biopsies 
from seropositive patients, and in none of the eight seronegative 
subjects. 
These results corroborate previous studies where, using PCR, 
HIV genome material was detected successively, within the epider-
mal and dermal samples evaluated separately [8]' in epidermal cells 
collected by suction blister procedure [12], and in highly purified 
LC by immunomagnetic separation [7]. These results and ours differ 
from those of Kalter et al lI0], who reported that there is no evi-
dence for in vivo HIV infection of epidermal cells. These divergent 
findings might be explained by some differences in dermo-epider-
mal separation techniques. Such results do not allow us to identify 
the phenotype of cells harboring the HIV -specific DNA sequences. 
IN VITRO, HIV-1 INFECTION OF EPIDERMAL 
LANGERHANS CELL PROCEEDS VIA RECEPTOR-
MEDIATED ENDOCYTOSIS 
In vivo, LC are certainly involved in HIV infection because, on 
electron microscopy, rare LC were found forming buds or releasing 
viral particles [6,14]. In vitro, no electron microscope studies dem-
onstrated the permissivity of LC for HIV. We developed an infec-
tion procedure to investigate the infection mechanism and to pro-
vide evidence that LC present in partially purified populations of 
EC can be infected in culture. In vitro, such an infection should 
occur through a CD4-independent pathway because isolated LC 
lose their CD4 expression when they are dissociated from neighbor-
ing EC by means of trypsin [13]. However, these trypsin-treated 
cells remain able to bind viral envelope glycoprotein (gp 120) [13]. 
To determine whether these gp 120 specific receptors can mediate 
the entry of HIV -1, we followed the morphologic sequence of 
events when isolated LC were exposed for various time periods to 
HIV-1-carrying U937 monocytes. LC-enriched EC suspensions 
(106/ml) were co-cultured with chronically HIV -1- infected U937 
(HTLVIII-B isolate) for 1 h,2 h, 3 h, and 6 h (three experiments). 
LC-associated virions were observed 3-6 h after the co-culture of 
LC-enriched EC with HIV-1-carrying U937 cells. Progressively, 
virions localized in the microvillar space between monocytes and 
LC were bound and then internalized into the LC through c1athrin-
coated pits and coated vesicles (Fig 2). These organelles suggestive 
of receptor-mediated endocytosis show evidence that the uptake of 
HIV-1 into LC occurs by a pH-dependent pathway. We checked 
whether this route of entry for HIV into LC may be the infectious 
route by prolonging the time of co-culture between LC-enriched 
EC suspensions and HIV-1-infected U937 monocytes. Electron 
microscopy provided evidence that LC can be infected in culture 
and release virus particles at day 4 ( two experiments). HIV -1 was 
clearly seen budding and being released from epidermal LC. The 
use of co-culture of HIV -1 -carrying U937 cells with LC-purified 
EC suspensions permits determination of the ability of HIV -1 to 
enter and replicate in isolated LC that express no detectable levels of 
the CD4 receptor [13]. Other EC (keratinocytes or melanocytes) 
were unable to be infected in vitro. This observation encourages us 
to emphasize the point that LC, in genital mucosa, might playa role 
in the i~itial viral inoculation. The fact that LC seem to support 
rephcatlol~ of l!IV suggests th~t these cells may also play an impor-
tant part 111 Viral pathogeneSIS. Infected LC may favor systemic 
dissemination of virus from areas of inoculation to regional lymph 
nodes where they would serve as a constant source of infection for 
CD4+ T cells. It is easy to hypothesize a putative role for LC as a 
vector for virus dissemination, although the consequences of such 
an infection on the antigen-presenting function cannot be presently 
assessed. 
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Figure 2. Internalization process of HIV -1 particles by epidermal LC after 3 h (1, 2) and 6 h (3, 4) of co-culture with HIV -l-carrying U937 cells. Some 
virions are tightly bound to an LC membrane (1). then are internalized through clathrin-coated pits (opw arrow) and progressively enclosed in small thick wall 
vesicles (closed arrow) localized near the LC membrane (2-4); bar, 100 nm. 
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